Vincere Biobank Research Protocol

NCT ID: NCT05954299

Last Updated: 2023-12-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

5000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-07-18

Study Completion Date

2038-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Vincere Biobank aims to make quality biospecimens and associated clinical data available for research studies related to advancing medicine and improving care for patients, including cancer screening, treatment, and care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Cancer Biobank Biorepository

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal

Participants and donor samples without disease (ex: non-cancer)

No interventions assigned to this group

Disease state or condition

Participants and donor samples with known disease or condition (ex: cancer)

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age or older; any gender
* Able to donate a blood, urine, tissue, and/or other biospecimen sample
* Able to provide informed consent to participate in the study

Exclusion Criteria

* Minors, under the age of 18 years
* Individuals who lack the capacity to give informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vincere Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vershalee Shukla, MD

Role: PRINCIPAL_INVESTIGATOR

Vincere Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vincere Cancer Center

Scottsdale, Arizona, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Christine Lau, MD

Role: CONTACT

Phone: 480-306-5390

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Christine Lau, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VCC-BIOBANK-001

Identifier Type: -

Identifier Source: org_study_id